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Abstract 
 
Ovine paratuberculosis or Johne’s disease is an insidious mycobacterial infection of sheep capable 
of causing wasting and death. It has emerged in recent years in Australia as a cause of significant 
losses in some infected sheep flocks. MLA Project OJD.015 was commenced to enable a detailed 
longitudinal case study of an attempt to control the disease in a large self-replacing Merino flock at 
Gunning in NSW with an owner-estimated annual mortality rate up to 25%. Vaccination of the whole 
flock with exception of a small group in each age cohort was conducted, with documentation of the 
effects of vaccination and other strategies on mortalities and mycobacterial faecal excretion rates 
and mortalities in all age groups of animals. The study concluded that the significant decline in 
mortality risk from 24.2% to 2.85 during the study may only be partially attributed to the increased 
flock immunity following vaccination. By accompanying vaccination with extensive changes in flock 
management, including culling of clinical cases, sale of ‘at risk’ stock and introducing of 
replacements and reduction in stocking rates, control of the losses can be rapidly achieved in an 
infected flock with a high prevalence of OJD. This project has enhanced the knowledge and 
understanding of the performance of this vaccine under Australian conditions in a high OJD 
prevalence environment and recommends that field evaluation of the performance of the vaccine 
continue, particularly in low challenge environments.  
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Executive Summary 
 
Ovine Johne’s disease (OJD) is a fatal enteric infection of sheep by Mycobacterium avium 
subspecies paratuberculosis ‘S’ strain (Mptb.). OJD in the Australian environment has proven 
difficult to both diagnose and control. The disease has become increasingly important as despite 
efforts to control spread by regulation of sheep movements, the disease has continued to spread in 
Australia. Funds allocated to research the many aspects of this disease have included projects that 
have investigated the level of losses on affected farms and the efficacy of vaccination in the control 
of the disease.  
 
Project OJD.015 is a case study commenced in a single large self-replacing flock and former fine 
wool Merino stud farm at Gunning in NSW. The owner was concerned that rapid increases in losses 
of about 25% per annum were due to OJD. A study was commenced to measure the level of losses 
and determine the contribution of OJD to the loss. Further, as the owner was seeking to vaccinate 
the whole flock with Gudair™ OJD vaccine in an attempt to control the losses, an opportunity was 
presented to examine the efficacy of this strategy. Whole flock vaccination commenced in May 2000 
and was completed in September 2000. To assist the research, a cohort of unvaccinated control 
sheep from each age group was left, to enable comparisons of mortality and Mptb. shedding data 
between vaccinates and controls over the course of the study.   
 
Over the 4-year study period, adult sheep mortality declined significantly in the Merrill flock. By 
completion of the study in 2004, mortalities were uncommon, due to a decline in the flock mortality 
risk from 24.2% to 2.8%, mostly attributed to a decline in the OJD attributable mortality risk from 
19.0% to 1.4%. However following commencement of vaccination, significant OJD mortalities did 
continue, particularly in adult vaccinates.  The prevalence of faecal shedders declined from a high to 
a moderate prevalence following vaccinating of 2-year-old sheep, although shedding at rates 
considered sufficient for transmission of infection did continue, particularly in wethers. However, a 
low prevalence of faecal shedding in sheep vaccinated at 3 or 8 months of age, suggests that 
vaccination is similarly efficacious in these age groups. This finding suggests that vaccination may 
be beneficial in sheep when delayed to weaner age or older, even when exposed to a heavily 
contaminated environment since lambing. A decline in the prevalence of Mptb. shedders in the 
unvaccinated control sheep during the project was also observed. However it is considered more 
likely that a series of management changes, including the culling of clinical cases, sale of ‘at risk’ 
stock and introducing of replacements and reduction in stocking rates leading to a decrease in 
‘sheep-years at risk’, would have had more significant impact on pasture contamination with Mptb. 
than the whole flock vaccination strategy.  
 
In conclusion, whilst an increase in flock immunity from whole flock vaccination may have 
contributed to the control of OJD, it was probably a minor component of the successful control 
program achieved over such a short time frame. The study concludes that by accompanying 
vaccination with intensive management changes, a significant decline in the risk of OJD mortality 
can be obtained and rapidly lead to control of OJD in a heavily infected flock. As the study was 
conducted in a single environment with high mycobacterial challenge, which may have provided 
sustained stimulation of flock immunity, it is recommended that field evaluation of vaccine 
performance be conducted in low challenge environments.    
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1 Background and Industry Context 
1.1 Introduction 
 
Johne’s disease is an important disease of ruminants worldwide which is often difficult to control and 
usually fatal. It is caused by enteric infection with Mycobacterium avium subspecies paratuberculosis 
(Mptb.). Aside from production losses due to Johne’s disease in farmed animals, recent speculation 
of a potential zoonotic link with Crohn’s disease and hence food safety issues has further enhanced 
interest in this infection. Ovine paratuberculosis or ovine Johne’s disease (OJD) in Australia is 
caused by the “S” strains of Mycobacterium avium subsp. paratuberculosis (Mptb) (Whittington et al, 
2000). It was first diagnosed in 1980 on a property in the central tablelands region of New South 
Wales (Seaman et al, 1981) and has gradually spread to other areas of NSW and other states via 
movement of infected stock or local spread between neighbouring flocks (Sergeant 2001).  
Ovine Johne’s Disease (OJD) in Australia has become increasingly topical in recent years due to 
changes in government policies related to controlling the spread of the disease at both a state and 
national level. Nationally, an OJD Control and Evaluation Program (NOJDCEP) commencing in 
1998, was completed in 2004. Recently, a new national program for the control of OJD has begun 
with vaccination as a major focus of disease control, using GudairTM (CZ Veterinaria, Porrino, Spain) 
vaccine imported from Spain.  GudairTM vaccine contains a killed suspension of Mptb plus a mineral 
oil adjuvant and thiomersal as a preservative. It is approved for use by subcutaneous injection high 
on the neck behind the ear in sheep and goats in Australia. The vaccine is now accepted widely in 
the region where OJD has become endemic and vaccination has become a major tool for the control 
program for ovine paratuberculosis in Australia. Work conducted in this trial has contributed to this 
acceptance of the vaccine by industry.   
One of the greatest impediments to control of OJD in Australia has been lack of understanding and 
acceptance that the disease can lead to significant losses on many infected farms. This led to delays 
in the diagnosis of OJD on infected farms and failure to implement on-farm disease control 
strategies. With Gudair™ vaccine not available for wider use until registration in April 2002, prior to 
that time many producers chose not to report adult sheep losses in fear of a diagnosis of OJD that 
resulted in imposition of regulatory controls on their stock movements at a time when a viable 
strategy for on-farm control was not identifiable. Significant mortalities in some flocks resulted.  
The Merrill flock near Gunning was particularly affected by OJD, reporting an estimated annual loss 
in 1999-2000 in the order of 25% of adult sheep. In early 2000, the owner approached the Faculty of 
Veterinary Science Sydney University to assist, with a request to commence whole flock vaccination 
against OJD. Support was then sought for inclusion of Merrill in vaccine field trial work and 
presented to the Chief Veterinary Officer (CVO) and Chief Division of Animal Industries (CDAI) of 
New South Wales Agriculture. Permission was granted to commence whole flock vaccination at 
Merrill under the NSW Agriculture permit for experimental use of the vaccine in infected flocks, 
provided the proposed vaccine research to evaluate the whole flock vaccination strategy would be 
conducted. Whole flock vaccination commenced at Merrill in May 2000.  
Accurate estimation of mortality rate in OJD infected flocks in Australia has proven difficult, with 
estimations reliant on producer observation and inventory records. The mortality rate was of 
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particular importance with the decision to limit pre-permit experimental use of Gudair™ vaccine to 
flocks with annual mortality rates exceeding 5%. This study proposed a structured approach to more 
accurately determine mortality rate estimations in a flock, which appeared from anecdotal reports, to 
have the highest mortality rate attributed to OJD on record. Further, the permission to proceed with 
the whole flock vaccination strategy provided a unique opportunity to investigate the efficacy of the 
vaccine in adults in a heavily OJD infected commercial flock.  Mortality rates, seroprevalence and 
faecal excretion of Mptb. were to be used as indicators of the effect of whole flock vaccination. 
 
 
1.2 Project objectives  
 
(i) To determine the mortality rate due to OJD in the flock before vaccination and to 
measure the change in mortality rate following vaccination. 
(ii) To determine the effect of whole flock vaccination on; 
a. The mortality rate of adult sheep due to OJD. 
b. The incidence of OJD in young sheep both directly, by protecting them from clinical 
disease and indirectly, by reducing environmental contamination. 
(iii) To investigate the relationship between the mortality rate in the flock and the effect of 
vaccination on;  
a. The seroprevalence of OJD in the flock and in each age group of the flock. 
b. The proportion of the two-year-old sheep that are excreting Mptb. 
c. The proportion of the flock having lesions of OJD at slaughter.  
In addition it was proposed to estimate the change in pasture contamination by OJD from vaccinated 
adult sheep, by measuring faecal excretion rate of Mptb. Following a review of available faecal 
samples in storage, the 015 Extension project was developed with the additional objectives: 
(iv) To determine the Mptb. excretion rates in tagged 1998drop (2-year-old) sheep collected 
in 2000, prior to their vaccination in 2000, compared with their excretion rates at ages 3 
to 5, in vaccinated and unvaccinated sheep 
(v) To determine the Mptb. excretion rates in tagged 1999 drop sheep (3-year-old) 
vaccinated (at 8 months of age) and unvaccinated sheep, collected in 2002, and compare 
with the rates in tagged 2000 drop sheep (2-year old) vaccinated (at 3 months of age) 
and unvaccinated sheep, collected in 2002  
(vi) To examine the relationship between vaccination lesions and presence of OJD lesions by 
histology 
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2 Methods 
2.1 Farm management, inventory, vaccination and ‘controls’ 
 
Paratuberculosis was diagnosed in the Merrill flock in 1996 when annual sheep losses from all 
causes were estimated to be between 3-5%. At that time the flock grazed 1,420 Ha and comprised 
about 10,000 adult sheep. In 1997, a cell grazing system was introduced involving management of 
the flock in mobs of up to 5,000 sheep, in paddocks of about 10 Ha, with a change of paddocks 
every 2 to 3 days. Weaner sheep were run separately from adult sheep until they were about 15 
months of age. Shearing occurs in August-September and lambing in September-October. Ewes 
were set-stocked during lambing.  
 
In 1999, the year preceding the trial and following a review of his inventory records, the producer 
estimated the annual mortality rate at Merrill to be about 25%. This was considered to be entirely 
due to OJD, resulting in a request by the producer to gain access to Gudair™ vaccine. The vaccine 
was unregistered at the time but field evaluation studies were being conducted in a number of 
central tablelands flocks, under a permit issued to NSW Agriculture. At the time the study 
commenced in 2000, the flock enterprise had reduced in size to approximately 1,000 Ha and 9,000 
adult sheep. In 2001, significant management changes were implemented to combat the 
increasingly severe drought conditions. Sheep were sold on several occasions during the year and 
the remaining sheep were grazed at increased stocking rates to facilitate hand-feeding, provision of 
water and to enable close monitoring of feed intake and changes in body condition. Supplementary 
feed included chopped straw, palm kernels, commercial mineral mix and the best available protein 
supplement.  
 
The study was conducted over a four-year period.  This time period was divided into study years 
with each study year commencing and finishing at shearing in August to facilitate the comparison of 
post-mortem and inventory data. The study commenced in 2000-2001 as Year 0 and completed in 
2003-2004 as Year 3.  The property was visited four times in each study year and necropsies were 
conducted on all sheep dying within a five-day period.  The initial sampling period was conducted 
pre-vaccination.  Vaccination of all animals commenced following this sample period and at lamb 
marking in each subsequent year.  All animals in the flock were vaccinated in Year 0, except for a 
small group of 150 (75 ewes, 75 wethers) ear tagged, numerically identified animals in each age 
cohort, which remained non-vaccinates for the duration of the trial.  The non-vaccinates were always 
run as part of the main flock, with their vaccinated cohorts and comprise about 7% of each age 
group born after 1996.  For additional comparisons between vaccinates and non-vaccinates over 
time, commencing in April 2000, 100 vaccinated sheep (50 ewes, 50 wethers) in each age cohort 
were ear tagged for subsequent identification. Faecal samples were collected from randomly 
selected sheep in age classes born after 1996 and that were ear-tagged and allocated to vaccinated 
and non-vaccinated ‘control’ groups.   
 
Between May and August 2000, the owner vaccinated the entire flock of about 8000 sheep, except 
for the tagged non-vaccinated ‘control’ groups described.  In the January of subsequent years, only 
3-month-old spring born lambs were vaccinated. The first group of these, born in 2000, were faecal 
sampled for inclusion in subsequent faecal excretion studies. All adults vaccinated throughout the 
period of the study were identifiable by age from coloured stud tags so it was possible to identify and 
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randomly select tagged and non-tagged vaccinated sheep in later years for faecal sampling.  
Animals from ewe and wether flocks were identified and recorded separately to reflect the property 
management structure. 
 
Being a field trial in a commercial flock, the trial was managed in partnership with the producer. 
However the decisions on stocking rate and flock profile throughout the trial were largely made by 
the producer without close consultation with the research group and in response to a number of 
factors. These included the increasing severity of the 2002-2003 drought, improved returns for 
sheep meat, better recognition and culling of groups of sheep at risk of dying of OJD and the desire 
by the owner to obtain a financial return via salvage slaughter of sheep that would otherwise be of 
minimal value and were likely to die on the property. These initiatives led to significant changes to 
the flock profile throughout the trial, initially by replacement of many breeding ewes with purchased 
wethers and then intensive de-stocking of sheep in Year 2 as a result of the drought. A significant 
decline in the mortalities was recorded during the trial, suggesting that close attention to flock 
inventory data was necessary to gain a more accurate estimate of the sheep numbers ‘at risk’ of 
developing OJD. 
 
To gain more accurate information on the total number of adults in the flock ‘at risk’ of developing 
OJD within a dynamic flock profile, the total number of ‘sheep-years at risk’ was calculated for each 
year of the study (see Section 3.2.2 for details). Total sheep numbers in the flock ranged from about 
7,500 to almost 10,000 over the period of the study.  
 
 
2.2 Mortality data and mortality risk estimations 
 
2.2.1 Mortality data 
 
Animals examined in quarterly necropsy study  
 
Within each 5-day post-mortem visit, all sheep that died and were collected within this period were 
submitted for necropsy. A total of 82 sheep were submitted to this procedure over the 4 years of the 
trial. From these sheep, clinical ante-mortem and gross necropsy information was recorded and 
samples taken for histopathology to assist with diagnosis and to identify the presence or absence of 
microscopic lesions indicative of OJD infection.  For histological examination, samples were taken of 
the ileocaecal junction, ileocaecal lymph node and a cross-section of the terminal ileum within 10cm 
of the ileocaecal junction. These tissues were preserved in 10% buffered formalin, processed by 
routine methods, stained with both Haematoxylin & Eosin and Ziehl-Neelson stains and examined by 
light microscopy. Samples of contents were also taken from the abomasum and small intestine as 
washings for total worm count estimations. 
 
The most likely causes of death were determined from necropsy data and material collected at the 
time of necropsy.  The significance of the presence of OJD to the animal’s death was derived 
following histopathological examination and grading of lesions in tissues by the modified Perez 
system (Appendix 1). If a slide did not present with any lesions suggestive of OJD it was categorized 
as NSL, that is, not having a lesion consistent with a diagnosis of OJD. Those slides where a Perez 
Type 1 lesion was observed, although considered suggestive of OJD, were not included as 
indicating a diagnosis of OJD as pathology of the intestinal mucosa was not observed in this 
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category and the subtle lesions present were not likely to have contributed to clinical signs of OJD. 
Those slides where Type 2 or Type 3a lesions were identified were considered infected with OJD 
but the lesions were not considered sufficiently severe to have contributed to the death of the animal 
from OJD. Sheep were then classified according to “the most likely cause of death” by a system we 
developed that considered all available evidence from the clinical and pathological examinations 
(Figure 1).  
 
Sheep were classified as OJD having contributed to their death when there was histopathological 
evidence of severe OJD infection, indicated by the presence of an advanced, diffuse granulomatous 
enteritis scored as a 3b (multibacillary) or 3c (paucibacillary).  Sheep with less severe OJD lesions 
on histopathology were classified as OJD present but unlikely to have contributed to their death.  
Sheep with no evidence of OJD infection on histopathology were classified as having died from 
other causes. 
 
Figure 1. Classification of the “most likely cause of death” following post mortem 
examination 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Animals examined in extension of pathology studies  
 
Additional pathological studies were conducted to further investigate the nature of the lesions in 
vaccinated and unvaccinated sheep that were at risk of dying from OJD and other causes during the 
study. This study was of material collected from an additional 198 sheep from the property however 
due to decomposition, only 184 sheep were considered suitable for histological study. This included 
three cohorts of sheep that were suffering from ‘wasting’ and had been placed in the ‘hospital mob’. 
The ‘hospital mob’ consisted of culls from the ‘tail’ of each sheep mob, being mostly sheep at or 
below a condition score of 2 on a scale of 1 to 5.  
 
Dead or 
moribund 
sheep  
Evidence of 
OJD infection 
(Histo +ve) 
OJD did not 
contribute to 
death 
No evidence of 
OJD infection 
(Histo –ve) 
OJD most likely to have 
contributed to death 
- Histo score of 3b or 3c  
- With or without clinical and/or 
pathological evidence of other 
disease state/s 
OJD unlikely to have 
contributed to death 
- Histo score of 1, 2 or 3a 
- With or without clinical and/or 
pathological evidence of other 
disease state/s 
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Group 1 comprised 95 moribund sheep that were euthenased and necropsied from the ‘hospital 
mob’ at the commencement of the project pre-vaccination in 2000. Group 2 included 11 sheep 
necropsied from the ‘hospital mob’ post-vaccination in 2001 and 2002. Group 3 comprised 78 sheep 
with clinical signs of severe wasting with condition scores of 2 or less. The sheep were sold for 
salvage slaughter at Wollondilly abattoir with data collection at Wollondilly on 17th September, 2001.  
 
These groups provided 95 unvaccinated sheep and 89 vaccinated sheep for comparison. Data 
recorded included ear-tag colour, age of sheep, size and texture of vaccination injection site lesion if 
present, and gross signs of thickening of the intestine with or without lymphatic cording, if present. 
Intestinal lesions were graded on a scale of 0 (nil) to 5 (severe), reflecting lesion severity. Lesion 
severity of 0 and 1 were considered unlikely to have gross evidence of OJD, with lesion severity of 2 
or more, considered likely to have gross evidence of OJD. Samples for histological examination 
were collected and processed as described. Due to the pace of the slaughter chain at Wollondilly 
abattoir, numbers of sheep with spread of vaccination site lesions to the prescapular lymph node 
were not recorded, although samples were taken from several injection site lesions including one 
with extension of the lesion to the prescapular lymph node. Confirmation of sheep ages at necropsy 
or slaughter for Groups 2 and 3 was obtained by consideration of the ear tag colours and time of 
vaccination with Gudair™ vaccine was identified (Table 1).  
 
Table 1. Vaccination schedule for sheep inoculated with Gudair™ vaccine at Merrill and examined 
by histological examination following euthanasia or slaughter. 
 
Sheep vaccinated Date of vaccination
Months 
since 
vaccination 
at time of 
collection 
Number of 
sheep in 
sample 
population* 
2100 lambs (1999 drop) 17/05/2000 16 11 
2460 ewes in lamb and all of an 
adult age 12/08/2000 13 
3500 wethers all of an adult age 19/08/2000 13 
 
78 
*Note: seven sheep had lost identifying ear tags so age unknown and data on gender not collected 
for all sheep (note only one week separated vaccination dates for sampled adults) 
 
2.2.2 Mortality risk estimations 
Crude mortality rates were calculated using sheep inventory records prepared from counts of sheep 
at the start of the year, being at shearing in August. The crude mortality rate was calculated by 
dividing the number of dead adult sheep identified during the year by the opening number, being the 
number of sheep present at the start of the year at shearing.  
 
However in Year 2, a marked change in the pattern of sheep sales occurred with significant numbers 
of sheep sold as a result of the drought. Consequently, we considered that crude mortality rate 
calculations based on the opening number of sheep seriously under-estimated the risk of mortality 
for sheep in Year 2.  We therefore defined the term ‘sheep-years at risk’ as a more accurate 
estimate of the average number of sheep present during each year. By examination of all available 
inventory records collected throughout the year an estimate of the number of sheep present at the 
commencement of each month was determined and the average number of sheep present for each 
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month determined by taking an average of the numbers of sheep present at the start of consecutive 
months. The ‘sheep-years at risk’ was then calculated from the average monthly inventory over the 
12 months of each study year. 
 
The ‘mortality risk’ was then calculated by dividing the number of dead adult sheep for the year by 
the number of sheep-years at risk, and represents the risk of mortality faced by each sheep during 
the one-year period. In all cases, mortality rates and mortality risk refer to sheep aged 12 months or 
more at the start of each study year. The OJD or paratuberculosis-attributable mortality risk was 
calculated by multiplying the mortality risk by the proportion of each year’s deaths attributed to 
paratuberculosis at post-mortem examination. 
 
2.3 Faecal excretion prevalence 
 
Faecal samples were collected annually from all ear-tagged (individually identified) sheep and from 
a random selection of non-tagged vaccinated sheep (range n = 23 to 64) in the ewe and wether 
flocks and stored at –80°C. Faecal samples from animals within treatment groups (vaccinated, non-
vaccinated; male, female; 3-month-old, 8-month-old, 2-year-old, etc) were randomly allocated to 
pools (n=5 sheep/pool) for pooled faecal culture, which was undertaken using standard methods. 
The prevalence of sheep shedding Mptb. in faeces was estimated from the total number of pools, 
number of pools positive and number of samples per pool using the method of Williams and Moffitt 
(2001).  The weeks of incubation required for cultures to develop peak growth index was also 
recorded, being inversely related to the number of viable organisms inoculated into the culture 
media, and so to shedding levels in sheep.  
 
Due to the small sample sizes, statistical analyses were not intended to be done but trends were 
evaluated in data that were presented graphically. Faecal culture was by modified BACTEC 12B 
radiometric culture and direct confirmation by IS900 PCR.  Following a review of available faecal 
samples in storage, an extension to the project was developed to explore shedding rates in different 
age cohorts vaccinated at different times. The groups identified for inclusion in the faecal excretion 
study were animals vaccinated at ages 3 months, 8 months and 2 years, calculated as the median 
age of each group assuming a joining period of 8-10 weeks. 
 
2.3.1 Excretion experiment 1  
Excretion experiment 1 aimed to determine whether vaccination of sheep older than 3 months of age 
was effective. This has been an important question raised by producers considering OJD 
vaccination. A common observation has been that many producers find that the complexity of 
procedures already conducted at lamb marking means that safe use of OJD vaccine at marking is 
difficult. OJD vaccinating at weaning or even at later musters is not uncommon. As lambs were 
vaccinated at 8 months of age at Merrill, this cohort of sheep could assist in providing answers to the 
efficacy of vaccinating later than the approved recommended age (4-12 weeks). 
 
PFC was conducted on the ear-tagged sheep at 2 years of age, following vaccination as lambs at 
age 3 months (including both the 2000 and 2001 lamb-drops) or at age 8 months. The ages, times of 
sample collection and sample sizes were recorded (Table 2). Prevalence of shedding of Mptb., 
weeks to reach peak growth index, numbers of serological reactors as assessed by ELISA (tested 
with CSL Parachek) and an estimate of possible mortalities were recorded as the numbers of sheep 
presenting each year. 
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Table 2 Details of animals, vaccination and testing for excretion experiment 1  
 
Group in Figure 1  2 yr 8 mth 3 mth 3 mth (+1yr) 
Year of birth 1998 1999 2000 2001 
Year of vaccination 2000 2000 2001 2002 
Year of sampling for PFC   2000 2001 2002 2003 
Age at vaccination 2 yr 8 mth 3 mth 3 mth 
Age at sampling for PFC 2 yr 2 yr 2 yr 2 yr 
No. vaccinates sampled (wether flock)a 48 46 33 21 
No. controls sampled (wether flock) b 55 20 53 47 
No. vaccinates sampled (ewe flock) a 50 30 45 50 
No. controls sampled (ewe flock) b 60 54 50 35 
a Number of vaccinates tagged at each time point was 50 in each of ewe and wether groups.  
b Number of controls (non-vaccinates) tagged at each time point was 75 in each of ewe and wether groups. 
 
2.3.2 Excretion experiment 2  
This experiment aimed to determine whether shedding rates were lower in sheep vaccinated at age 
2 years, compared to non-vaccinated controls. This is a critical question for evaluating the value of 
whole flock vaccination strategy, particularly as it was apparent that sheep vaccinated as adults 
continued to die. However producers and their advisors were keen to know whether vaccination of 
adults may delay or reduce the level of shedding of mycobacteria. This might suggest that adult 
vaccination could provide a potentially strategic means of hastening de-contamination of the 
environment with Mptb. in medium to high prevalence flocks. 
To examine this, the effect of vaccination at 2 years of age, PFC was conducted on faecal samples 
collected at the time of vaccination of 2-year-old sheep at the commencement of the trial. PFC was 
also conducted on faecal samples collected at annual intervals until these sheep were age 5 years. 
Both ear-tagged and randomly sampled animals were included with ages, times of sample collection 
and sample sizes recorded (Table 3). 
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Table 3 Details of animals, vaccination and testing for experiment 2 
 
Group in Figure 2 2 yr 
tagged 
3 yr 
tagged 
3 yr 
random 
4 yr 
tagged 
4 yr 
random 
5 yr 
tagged 
5 yr 
random 
Year of birth 1998 1998 1998 1998 1998 1998 1998 
Year of vaccination 2000 2000 2000 2000 2000 2000 2000 
Year of sampling for 
PFC  
2000 2001 2001 2002 2002 2003 2003 
Age at vaccination 2 yr 2 yr 2 yr 2 yr 2 yr 2 yr 2 yr 
Age at sampling for 
PFC 
2 yr 3 yr 3 yr 4 yr 4 yr 5 yr 5 yr 
No. vaccinates sampled 
(wether flock) a 
48 37 30 23 56 19 25 
No. controls sampled 
(wether flock) b 
55 26 0 18 0 0 0 
No. vaccinates sampled 
(ewe flock) a 
50 35 0 33 64 9 23 
No. controls sampled 
(ewe flock) b 
60 37 0 29 0 25 0 
a Number of vaccinates tagged at each time point was 50 in each of ewe and wether groups.  
b Number of non-vaccinates tagged at each time point was 75 in each of ewe and wether groups. 
 
2.4 Serological prevalence 
 
Serum samples were collected following jugular venipuncture from selected unvaccinated sheep 
only, as a possible indicator of the prevalence of OJD infection in the flock. Despite the known 
insensitivity of serological tests that examine humoral antibody, as a means of diagnosis of OJD, a 
profile of ELISA titres in the control sheep through the trial was considered a potentially valuable 
indicator of numbers of sheep developing clinical OJD, assuming that expression of humoral 
antibody is most likely an indication of onset of shedding. Samples were not collected from 
vaccinated sheep as a high rate of seropositive reactions from the vaccination would be expected.  
 
The numbers of animals by age and year of study are detailed in Table 4. The samples were stored 
at  –20°C until required for analysis and then tested using the CSL Parachek ELISA by CSL, 
Parkville Victoria. 
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Table 4. Numbers of serum samples tested by Parachek™ ELISA of non-vaccinated sheep by age (both 
sexes) at sampling and year of study 
  
Age (yrs) Year  0 Year 1 Year 2 Year 3 
0.6 150 146 142 102 
1.6 148 107 123 90 
2.6 104 61 83 70 
3.6 110 59 43 17 
4.6 101  49 16 
5.6 98   7 
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3 Results 
3.1 Farm management and inventory 
 
The total number of adults in the flock ranged from about 7,500 to almost 10,000 over the period of 
the study (Table 5) that commenced in 2000-2001 (Year 0) and was completed in 2003-2004 (Year 
3).  Significant changes in the flock profile occurred during the study. Replacement of females with 
purchased wethers and intensive de-stocking of aged sheep of both genders due to OJD and 
drought, commenced in Year 0 of the study, leaving a low proportion of the flock in the 4-5 year age 
cohort (Table 5).  
 
Table 5. Inventory data providing flock profile for the 4 years of the study 
 
  Year 0 Year 1 Year 2 Year 3 
Gender               Age (yrs) OPEN OPEN OPEN OPEN 
Ewes                       1-2 3176 2516 2625 2090
                           2-3 1588 1258 1313 1045
                           3-4 1270 1006 1050 836
                                4-5 318 252 262 209
Wethers                   1-2 2763 4476 5385 3671
                           2-3 1382 2238 2693 1836
                            3-4 1105 1790 2154 1468
                            4-5 276 448 538 367
Hoggets 2460 2079 1534 1621
Male lambs 1102 977 648 718
Female lambs 1230 1040 767 813
Ram Hoggets 128 62 119 93
Rams 74 70 72 62
TOTAL 8601 9203 9735 7537
 
Due to increasing severity of the drought, de-stocking intensified in Year 2 and is considered to have 
contributed to a substantial decline in both sheep numbers and mortalities recorded in Year 3 of the 
study (Tables 5, 6).  
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Table 6. Summary of inventory figures, sheep-years at risk and mortalities from inventory for all years 
of the study 
  
Year of 
study 
Opening 
sheep 
numbers 
Sheep yrs at 
risk 
Mortalities from 
inventory 
 
 
Mortality risk 
0 8601 8030 1947 24.2 
1 9203 8622 1836 21.3 
2 9735 7481 1162 15.5 
3 7537 5571  149 2.8 
 
 
 
3.2 Mortality data and mortality risk estimations 
 
3.2.1 Animals examined in quarterly necropsy study 
A total of 82 sheep died and were collected over the 4 years of the trial during the four annual 5-day 
necropsy periods. Following histological study it was found that the percentage of sheep where OJD 
contributed to death was 78.7%, increasing to 87.5% of sheep in Year 1, then declining to 78.6 in 
Year 2 and 50.05 in Year 3. Note however that few animals were available for examination in years 
2 and 3 of the study. This data was used to calculate the mortality risk, OJD extrapolated mortality 
risk and ‘other disease’ mortality risk (Table 7).  
 
Table 7.  Summary of numbers of animals necropsied in quarterly post mortem studies, plus mortality 
risk, OJD mortality risk and  ‘other disease’ mortality risk.  
 
Study 
year 
Total adults OJD 
contributed 
to death % 
Mortality 
risk 
OJD 
attributable 
mortality risk 
Other 
disease 
mortality 
risk  
0 42 78.7 24.2 19.0 5.2 
1 24 87.5 21.3 18.6 2.7 
2 14 78.6 15.5 12.2 3.3 
3 2 50.0 2.8 1.4 1.4 
 
Note: inventory records of ‘sheep-years at risk’ used to derive overall mortality risk, OJD-attributable 
mortality risk (due to the contribution of OJD) and ‘other disease’ mortality risk (where it was 
considered OJD did not contribute to death, plus deaths from other causes) estimations.  
 
 
Animals examined in extension of pathology studies 
 
Three cohorts of sheep that were moribund or sold for salvage slaughter at Wollondilly abattoir 
provided 198 sheep of which 184 were suitable for complete examination. This included 95 
unvaccinated sheep in Group 1, with 46% (44) 2.5years of age at necropsy (range 1.5 to 5.5). The 
11 Group 2 vaccinated sheep were all over 4 years of age. Of the 78 vaccinated sheep in Group 3, 
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46% (36) sheep were 3 years of age (range 2 to 7 years of age). Gross evidence of thickening of the 
intestine suggesting OJD was present in 79% (75/95) of the Group 1 unvaccinated sheep and in the 
majority of vaccinated sheep, including 82% (9/11) of Group 2 sheep and 94% (73/78) of Group 3 
sheep. However data for histopathological examination of the three groups of sheep categorised 
according to the modified Perez system (Table 8) indicates that only 75%, 73% and 86% of these 3 
groups had histological lesions of OJD respectively. Thus of 184 sheep, 85.3% (157) had gross 
lesion of OJD, with 79.3% (146) having histological lesions of OJD. 
 
Table 8. Results of examination of sheep from extended pathological studies 
 
% sheep with histological OJD 
lesion (Perez category) 
% sheep with 
no diagnosis of 
OJD 
Sheep 
Group 
No. 
No. 
sheep 
examined 
% OJD 
Diagnosis 
(Total) 
3c 3b 3a, 2 1 NSL 
1  
 
95 
 
75 (71) 
 
25 (24) 
 
32 (30) 
 
18 (17) 
 
16 (15) 
 
9 (9)  
2  
 
11 
 
73 (8) 
 
9 (1) 
 
45 (5) 
 
18 (2) 
 
9 (1) 
 
18 (2) 
3  
 
78 
 
86 (67) 
 
56 (44) 
 
21 (16) 
 
9 (7) 
 
14(11) 
 
0 
 Data presented as percentages with numbers of sheep in brackets 
 
Table 8 includes data on the percentage of sheep that were found not to have a lesion considered 
capable of causing clinical signs of OJD, which includes those categorized as NSL or having a 
Perez Type 1 lesion on histological examination, despite presence of intestinal thickening in some at 
slaughter. Other diagnoses were not made. No effect of age at vaccination on lesion category was 
observed.  
 
Vaccination injection site lesions were present in 57% of the vaccinated sheep (5/11 of Group 2 and 
30/78 of Group 3), mostly located on the side of their neck in the vicinity of the presumed injection 
site. Extension of the lesion to the prescapular lymph node was noted in several sheep in Group 3 at 
slaughter. The size of these lesions averaged 2.6cm in diameter and ranged between 0.5 to 5cm.  
Oil droplets were regularly identified in the vaccine injection lesions on histological examination, 
accompanying locally extensive severe granulomatous to necrotising cellulitis. Examination of 
affected prescapular lymph nodes identified lesions of locally extensive severe granulomatous to 
necrotising lymphadenitis accompanying numerous oil droplets surrounded by macrophages and 
giant cells. 
 
The pathology data from Group 3 was examined for a possible relationship between the presence 
and type of OJD lesions and the presence of a vaccination injection lesion. A total of 38.5% (30/78) 
of these sheep had injection site lesions and of these sheep, 90% had histological lesions confirming 
a diagnosis of OJD. Lesion category of vaccinates with injection lesions is provided in Table 9. 
 
Comparison of data in Tables 8 and 9 suggest that the lesion type present in Group 3 sheep with 
vaccination injection site lesions, was similar to that in sheep with or without vaccination injection 
site lesions.  
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Table 9. Results of examination of sheep with vaccination injection lesions 
 
% sheep with histological OJD 
lesion (Perez category) 
% sheep with 
no diagnosis of 
OJD Sheep Group 
No. 
No. 
sheep 
with 
injection 
lesions 
% OJD in 
sheep 
with 
injection 
lesions 
(Total) 
3c 3b 3a, 2 1 NSL 
3  
 
30 
 
90 (27) 
 
60 (18) 
 
20 (6) 
 
10 (3) 
 
0 
 
10 (3) 
 
3.3 Faecal excretion prevalence  
 
3.3.1 Experiment 1. Efficacy of vaccination at ages 3 months and 8 months 
Prevalence of faecal shedders  
 
Data for the prevalence of shedding of Mptb. in ewes and wethers vaccinated at different ages is 
shown in Figure 2. The prevalence of shedders in 2-year-old sheep pre-vaccination are included to 
indicate the prevalence that could be expected in 2-year-old sheep on this farm in the absence of 
vaccination or other control measures. Those vaccinated at ages 3 months in two successive years 
and at 8 months, were tested at 2 years of age.  The 3 groups, vaccinated at age 3 months in two 
successive lamb drops and age 8 months, had a lower prevalence of faecal shedders at age 2 years 
than non-vaccinated control groups (Figure 2). This was particularly evident in the ewe flock where 
there were no positive pooled cultures in vaccinated groups. Two-year-old sheep in both the ewe 
and wether flocks had a high prevalence of faecal shedders (20-40%) at the time of vaccination of 
the 3 and 8-month-old sheep (Figure 2). 
 
Figure 2. Prevalence of shedding of  Mptb. in ewes and wethers  in groups of sheep 
vaccinated at ages shown.  
Point prevalences are given by the height of the shaded bars (with the value also shown), with 95% 
confidence limits indicated by error bars. Note that those vaccinated at 2 years of age were tested at the 
time of vaccination. 
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Level of shedding and prevalence of ELISA reactors   
 
The weeks of incubation required for cultures to develop peak growth index is inversely related to 
the number of viable organisms inoculated into the culture media, and so to shedding levels in 
sheep. The results for weeks to reach peak growth index suggest that sheep vaccinated at 3-8 
months of age had lower faecal shedding rates than controls (Table 10).  
 
Table 10. Level of shedding of Mptb, expressed as weeks to peak growth index, for faecal 
pools in each group for excretion experiment 1.  
 
 Age at vaccination 
Group 3 mths 8 mths 2 yrs 3 mths (+1year) 
 Vaccinate Control Vaccinate Control Vaccinate Control Vaccinate Control 
Ewes NA 5-7 NA 4-9 4-12 4-12 NA 5-8 
Wethers 7 4-6 7-12 5-6 3-7 4-12 NA 4-8 
 
NA = No growth indices as no positive pools recorded  
Note: The level of shedding is inversely related to weeks to peak growth index. 
 
About 6% of 2-year-old sheep unvaccinated sheep were ELISA positive. Too few sheep were tested 
to draw conclusions about prevalence at 2 years in the controls for sheep vaccinated at 3 and 8 
months of age, but there were positive reactors (Table 11). 
  
Table 11. Number of ELISA reactors in excretion experiment. Data are number positive out of 
number tested. 
 
 Age at vaccination 
Group 3 mths 8 mths 2 yrs 3 mths (+1year) 
 Vaccinate Control Vaccinate Control Vaccinate Control Vaccinate Control 
Ewes NA 1 of 17 NA 2 of 26 NA 3 of 47 NA 2 of 13 
Wethers NA 6 of 17 NA 0 of 7 NA 3 of 50 NA 1 of 20 
 
NA = No animals tested in vaccinate groups 
Note: only non-vaccinates were tested. 
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The proportion of vaccinated and control sheep presented for sampling in excretion experiment 1 
was variable. This was due to problems of incomplete muster at sample collection, culling or sales of 
tagged sheep, and mortalities due to all causes. However in general a higher proportion of 
vaccinates than controls was presented for shearing (Table 12). Animals in the 2 years age group 
were tagged in April 2000 and faecal sampled within one month of vaccination between July and 
August. As 4% of wether vaccinates were missing at shearing and a higher proportion of ewe and 
wether control sheep were missing at shearing, it is assumed that up to half of these control sheep 
may have died. Unfortunately an incomplete muster, due to difficulty of identifying the yellow tags in 
control sheep by the producer, is likely to have elevated the mortality estimations in control sheep in 
2000.  
 
 
 
Table 12. Percentage of 2 yr old sheep not presented for collection of samples for PFC. 
 
 
 Age at vaccination 
Group *2 yrs 3 mths 8 mths 3 mths (+1year) 
 Vaccinate Control Vaccinate Control Vaccinate Control Vaccinate Control 
Ewes 0 20 10 33 40 28 0 53 
Wethers 4 30 34 33 8 75 58 41 
 
*Animals in 2 years age group were tagged in April 2000 and faecal sampled within one month of vaccination 
between July and August, however a number of controls were missing at shearing following an incomplete 
muster, due to difficulty of identifying the yellow tags by the producer. 
 
 
 
3.3.2 Experiment 2. Changes in prevalence of OJD when sheep vaccinated at age 2 
years 
Prevalence of faecal shedders 
 
In excretion experiment 2, vaccine was administered to sheep at 2 years of age, and testing was 
conducted annually. Between 20 to 40% of 2-year-old sheep were shedding Mptb. in 2000 when 
they were vaccinated (Figures 2, 3).  
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Figure 3.  Prevalence of shedding of Mptb. from ewes and wethers in a group vaccinated at 2 
years of age, in randomly selected vaccinated sheep and in ear-tagged non-vaccinated 
controls at the ages shown.  
Point prevalences are given by the height of the shaded bars (with the value also shown; nt, not tested) while 
95% confidence limits are indicated by error bars. 
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2001, 2002 and 2003 when the sheep were aged 3, 4 and 5 years respectively (Figure 3). However 
this applied to both vaccinated and control groups in both ewe and wether flocks and to non-tagged 
randomly selected vaccinated sheep. In tagged wethers there were no shedders at 3 and 4 years of 
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random samples of untagged sheep from the main flock indicated that some vaccinated sheep were 
in fact shedding Mptb at age 3 and 4 years. In wethers, none of the controls appeared to be 
shedding at 3, 4 or 5 years of age. In ewes, a low prevalence of shedders was observed in 
vaccinates and controls at age 3 and 4 years, and in controls at age 5 years.  
 
Allowing for the small sample sizes, the results suggest that there were sheep shedding Mptb. in 
both ewe and wether flocks throughout the trial. The apparent reduction in the prevalence of faecal 
shedders between 2 years of age and 3, 4 and 5 years of age in both vaccinated and control sheep 
is most likely due to the departure due to mortality or culling of clinically affected sheep from the 
flock after 2 year of age, as reflected in the inventory records (Tables 5,6).  
 
Level of shedding and prevalence of ELISA reactors   
 
The level of shedding was determined from samples from animals individually vaccinated plus 
vaccinated animals randomly selected from the adult flock at each collection time point, being sheep 
vaccinated at 2 years and tested when 2, 3, 4 and 5 years of age. The level of shedding is inversely 
related to weeks to peak growth index. The data for sheep vaccinated when 2 years of age indicate 
that there is little difference in shedding rates between vaccinates and controls (Table 13). 
 
Table 13. Level of shedding, expressed as weeks to peak growth index for faecal pools in 
each group for experiment 2.    
 
Group 2 yrs  3 yrs  4 yrs  5 yrs  
 Vaccinate Control Vaccinate Control Vaccinate Control Vaccinate Control 
Ewes 4-12 4-12 6-7 4-5 5-6 5-6 na 4-7 
Wethers 3-7 4-12 11 na 6 na 5 na 
na = No growth indices as no positive pools recorded  
 
Serological results indicated that about 6% of 2-year-old sheep were seropositive at the time of 
vaccination (Table 14) with only one seropositive reactor of the seventeen sheep tested from the 3, 
4 and 5-year-old control cohorts. 
 
Table 14. Number of ELISA reactors in experiment 2. Data are number positive out of number 
tested. 
 
Group 2 yrs  3 yrs  4 yrs  5 yrs  
 Vaccinate Control Vaccinate Control Vaccinate Control Vaccinate Control 
Ewes na 3 of 47 na 0 of 6 na 1 of 8 na 0 of 3 
Wethers na 3 of 50 na nt na nt na nt 
na = note that only non-vaccinates were collected for testing 
nt = not available for testing 
 
The proportion of vaccinated and control sheep presented for sampling in excretion experiment 2 
was variable. Again this was due to problems of incomplete muster at sample collection, culling or 
sales of tagged sheep, and mortalities due to all causes. More than 25% of sheep present at 2 years 
of age were not present at shearing in subsequent years (Table 15). Note that as above (Table 12), 
the rate of presentation for control sheep aged 2 years was recorded following an incomplete 
muster, due to difficulty of identifying the yellow tags by the producer. However based on flock 
mortality figures for that year, up to half of these sheep are considered to have died. 
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Table 15. Percentage of sheep not presented for shearing the year of collection of samples 
for PFC.  
 
Group *2 yrs  3 yrs  4 yrs  5 yrs  
 Vaccinate Control Vaccinate Control Vaccinate Control Vaccinate Control 
Ewes 0 13 30 46 30 58 82 64 
Wethers 4 24 26 67 50 81 62 100 
 
*Animals in 2 years age group were tagged in April 2000 and faecal sampled within one month of 
vaccination between July and August, however a number of control sheep were missing at shearing 
following an incomplete muster, due to difficulty of identifying the yellow tags by the producer. 
 
 
3.4 Serology 
 
Serum available from collections of six differing age groups of unvaccinated control sheep collected 
over the four years of the study was tested using the CSL Parachek ELISA (Table 16). No serum 
was available from 4.6 year olds in Year 1 and 5.6 year olds in Year 1 and 2. Despite a reduction in 
mortalities in years 2 and 3 the seroprevalence in all age groups over this period remained 
comparable with years 0 and 1 of the study.  Note that the 2.6year old cohort consistently had the 
highest rate of seroprevalence in all years of the study. 
 
Table 16. Seroprevalence (Parachek™ ELISA) of non-vaccinated sheep by age at sampling (both 
sexes) and year of study 
 
Age (yrs) Year 0 1 2 3 
0.6 2.67 0.68 0.00 4.9 
1.6 8.11 8.41 16.26 6.67 
2.6 13.46 19.67 22.89 20.00 
3.6 9.09 11.86 11.63 17.65 
4.6 12.87 NA 16.33 6.25 
5.6 10.20 NA NA 14.29 
 NA = not available 
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4 Discusson 
Due to the severity of OJD losses at the commencement of the study and the increasingly severe 
drought throughout most of the study period, the owner of this flock instituted a whole flock 
vaccination strategy, followed by a series of management initiatives. This led to a major change in 
the flock profile during the study period. Early work confirmed that OJD losses were at a very high 
prevalence in this flock. However as we became aware of the significant culling of groups of sheep 
‘at risk’ of dying from OJD, it became increasingly apparent that the annual opening and closing 
numbers obtained from the post-shears inventory were no longer an accurate estimate of the sheep 
at risk of developing OJD. We decided that consideration of the estimated monthly opening and 
closing numbers gave a more accurate estimate of the annual ‘sheep-years at risk’ and enabled 
observation of an association between the declines in mortalities, with the decline in the ‘sheep-
years at risk’. It is probable that this association largely reflects the significant changes to the flock 
profile, particularly in Years 2 and 3.  
 
The quarterly necropsy study with histological confirmation of percentage of mortality due to OJD, 
was an important method of establishing that the majority of losses were in fact due to OJD and that 
this data could be related to the annual losses from inventory, rather than other causes of mortality 
related to seasonal events. The mortality study data documents an increase in the OJD-attributable 
mortality rate from 78.7% in Year 0 to 87.5% in Year 1, followed by a decline to 78.6% in Year 2 and 
50% in Year 3 (although few animals were available for necropsy examination in years 2 and 3 of 
the study). This and the inventory data were used to calculate that remarkably, the mortality risk 
declined from 24.2% to 2.8%, with the OJD extrapolated mortality risk declining from 19% to 1.4% 
during the 4 years of the study. Interestingly there was no significant difference in OJD proportional 
mortality between years 0 and 2 and insufficient data for Year 3, indicating a reduction in both OJD-related 
mortality and mortality due to other causes. However, as the quarterly necropsy technique enabled only a 
small proportion of the total deaths each year to be examined in a relatively short time period, being 5% of the 
year the estimated values may not be particularly representative of the whole year, particularly later in the 
study when few animals were available for necropsy.  
 
At the commencement of the trial, almost nothing of the pathology of OJD in vaccinated sheep was 
known. Comparison of lesions from vaccinated and unvaccinated sheep of varying ages involved 
examination of three additional cohorts at necropsy or slaughter. Grossly detectable thickening of 
the intestine suggesting OJD was present in the majority of sheep in all cohorts, however 
histological examination confirmed that consideration of gross lesions alone regularly over-estimated 
the prevalence of OJD. Gross intestinal lesions suggesting OJD were found in 85.3% of sheep with 
79.3% having histological lesions of OJD. No correlations were found for any of the cohorts between 
the type of histological lesion and the degree of bowel thickening or the degree of gross signs. 
Sheep with severe gross pathology were not found to have one particular type of histological lesion 
while sheep with mild gross pathology were not found to have a different type of histological lesion. 
This suggests the degree of inflammation and not the type of histological lesion influences the visual 
appearance of bowel thickening. In addition, no effect of age at vaccination on lesion category was 
observed. 
 
An unusual finding in this study was the variation in the Perez scores between the vaccinated and 
unvaccinated groups. The percentage of unvaccinated infected sheep (Group 1) with multibacillary 
lesions was 32%, with 25% having paucibacillary disease. This compares to vaccinates (Group 3) 
with 21% having multibacillary lesions and 56% with paucibacillary disease. Other studies have 
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identified that it is usual to find a greater proportion of animals with multibacillary lesions  compared 
to animals with paucibacillary lesions in an OJD infected population. For example, Clarke and Little 
(1996) found 69% of a group of unvaccinated sheep to have multibacillary lesions and 31% to have 
paucibacillary lesions, with Carrigan and Seaman (1990) finding 88% of a group of unvaccinated 
sheep to have multibacillary lesions and 12% to have paucibacillary lesions.  
 
Initial interpretation of this observation was related to the hypothesis that the paucibacillary lesion 
may represent a more successful immunological response of the sheep to infection. Thus such 
sheep, whilst still dying of OJD, could have a much lower rate of excretion of Mptb. prior to death. 
However the time of data collection, time after and extent of vaccination in the flock, severity of 
infection on the property, and sampling errors could all be involved in the obvious difference in the 
pathological character of the groups. The observation deserves some discussion. 
 
Firstly, it is possible, although unlikely, that the observation of a predominance of pauciballary OJD 
in vaccinates could simply be a sampling error and that the ratio of the lesions would be similar to 
that in other flocks if more animals were examined. Secondly, it is more likely that these results 
reflect a bias in the distribution of lesions in the overall population of sheep due to temporal 
differences and/or effects of the drought, where the clinical condition of the sheep was as much due 
to malnutrition and other factors as it was to OJD (whereas previous studies were primarily of clinical 
cases of OJD without the confounding effect of drought conditions). Further, it is also possible that 
the finding of more sheep with paucibacillary lesions in Group 3 may represent a more rapid demise 
of OJD infected sheep with multibacillary lesions. In addition, as these cohorts were collected at 
different times, the time of data collection could have affected the type of histological lesion.  Group 
1 sheep were collected at the start of the investigation and Group 3 collected almost 18 months 
later, although in such a high prevalence environment, it may be assumed that levels of exposure 
are comparable in both Groups 1 and 3, despite the 18-month difference in collection times. An even 
further possibility is that Group 3 sheep are demonstrating a post-exposure vaccination response, 
with the vaccine possibly acting like a booster in the high Mptb. challenge environment from 
intensive grazing of Merrill. Perhaps this observation was a reflection of a property with a high 
infection status where the challenge potentially boosts the immune response, directing the 
developing lesions in a paucibacillary direction? However, in sheep where the disease is already too 
far advanced and the antigenic load is too great, a sufficient immune response is not created and 
the lesion develops in a multibacillary direction. If this observation is an immunological effect of 
vaccination in a high challenge environment, we might expect to see this finding on other high 
infection properties.  
 
The finding of a higher rate of paucibacillary lesions in vaccinated sheep prompted a separate 
project examining pathological findings on 56 adult-vaccinated sheep from a different property with a 
high infection status. However in this case the dominant histological lesion was multibacillary 
(unpublished observations). In conclusion, as this is a field observational study with numerous 
management factors involved in animal selection, plus the numbers of sheep examined were a 
limited proportion of the flock, we are reluctant to speculate further on the many potential 
contributing factors to this observation. 
 
Vaccination injection site lesions were present in 43% of the sheep, mostly located on the side of 
their neck in the vicinity of the presumed injection site. Extension of the lesion to the prescapular 
lymph node was noted and oil droplets were regularly identified in the vaccine injection lesions on 
histological examination, accompanying locally extensive severe granulomatous to necrotising 
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cellulitis. Examination of affected prescapular lymph nodes identified lesions of locally extensive 
severe granulomatous to necrotising lymphadenitis. These findings concur with other studies 
conducted on injection lesions from vaccinates (Windsor et al, 2005). The type of OJD pathology 
present in sheep with vaccination injection site lesions, was compared to that in sheep without 
vaccination injection site lesions. However no trends were noted, with no correlation between the 
presence of a vaccination injection site lesion and the presence of gross pathology or histological 
lesion type of OJD. This indicates that the presence of a vaccination injection site lesion is unlikely to 
influence the degree of bowel thickening or the formation of a particular type of histological lesion. 
Further, the presence of a palpable vaccination injection site lesion does not appear to be a useful 
indicator that adult sheep vaccinated with Gudair® have sufficient protection against the effects of 
OJD to alter the clinical outcome.  
 
The results of faecal excretion experiments 1 and 2 indicate that the prevalence of faecal shedders 
in this flock declined from a high to a moderate prevalence following vaccinating of 2-year-old sheep. 
However shedding did continue, particularly in wethers. In contrast, data on the prevalence of faecal 
shedding in sheep vaccinated at ages 3 months and 8 months, appears to suggest that vaccination 
is similarly efficacious in these age groups, particularly in the ewes. This finding suggests that 
vaccination can be beneficial in reducing excretion rates in sheep when delayed to as late as 8 
months of age, even when there is likelihood that they have been exposed to a heavily contaminated 
environment since lambing. Interestingly, all cohorts of control sheep that were age 3 months and 8 
months when non-vaccinated, when faecal sampled at age 2 years in 2002, had a lower prevalence 
of Mptb. shedders than 2-year-old sheep in 2000. This would appear to indicate a decline in the 
prevalence of shedders in the unvaccinated sheep during the project. Although the whole flock 
vaccination strategy may have contributed to a reduction in the level of environmental contamination 
with Mptb., it is considered more likely that the management changes were the predominant 
influence. These included the culling of clinical cases, changing the flock profile by sale of ‘at risk’ 
stock and introducing of replacements, plus significant reduction in stocking rates, leading to a 
decrease in ‘sheep-years at risk’. All would have had a major impact on levels of pasture 
contamination with Mptb. The management changes commenced in early 2000 and their practice 
intensified over the trial period so that by the completion of the trial, mortalities were uncommon.  
 
The serological and faecal culture results, particularly the Year 3 seroprevalence of 20% in 2.6-year-
olds and the faecal culture results showing persistence of shedding in non-vaccinated animals 
throughout the study, suggest that despite declining mortality rates, a continuing high level of 
infection was present in this flock throughout the study period. However, it would appear that even 
though the prevalence of OJD infection persisted through the study, by instituting dramatic changes 
in management practices combined with increasing effect of vaccination of the younger flock, the 
owner achieved a substantial reduction in mortality risk, particularly in the final two years of the 
study. 
 
The results of this study do provide illumination of the complexity of the question of whether whole 
flock vaccination with Gudair™ vaccine is a useful strategy in high prevalence flocks of adult sheep 
in Australia. The data were derived from a ‘real world’ study where the socio-economic reality of 
survival of a family business overwhelmed the scientific objectives of the project. Clearly, the 
management changes instituted by the owner are very likely to have greatly influenced the mortality 
rate. With the serological and faecal results suggesting that a high level of OJD infection persisted in 
the flock despite the rapid decline in mortality rate, it is very likely that the change in flock profile was 
a more significant impact on mortality rate than the effect of whole flock vaccination. However it is 
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also probable that vaccination may reduce Mptb. excretion rates in the survivors and thus contribute 
to a decrease in contamination levels, consequently reducing the risk of exposure of the infection to 
newborn lambs or other sheep. In conclusion, whilst a significant increase in flock immunity as a 
result of whole flock vaccination could be a factor that supported the control of OJD in the flock, it 
was probably a minor component of the successful control program achieved over such a short time 
frame. 
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5 Success in achieving objectives 
Determining the success or otherwise of the project requires consideration of the context in which 
the trial was initiated and the reality of the often differing expectations of the rural and scientific 
communities. The trial was initiated largely in response to demands from the rural community to 
assist a critical OJD mortality problem at a time of strident calls from the rural community for an 
alternative to regulation of OJD. Despite complete lack of information on the potential performance 
of the vaccine in Australian sheep in the Australian environment, there was immense pressure on 
regulatory policy-makers to permit the use of whole flock vaccination at Merrill, irrespective of 
concerns that there was little scientific justification for this strategy. The objectives of OJD.015 are 
listed below with comments on the achievement of each: 
(i) To determine the mortality rate due to OJD in the flock before vaccination and to 
measure the change in mortality rate following vaccination.  
This was achieved with annual flock and OJD-attributable mortality rates determined successfully 
from a combination of quarterly necropsy studies and examination of flock inventory data. Data 
indicate a drop in flock mortality rate from 24% to less than 3% and a drop in OJD-attributable 
mortality rate from 19% to 1.4% over the four years of the study. 
(ii) To determine the effect of whole flock vaccination on; 
(a) The mortality rate of adult sheep due to OJD. 
(b) The incidence of OJD in young sheep both directly, by protecting them from clinical 
disease and indirectly, by reducing environmental contamination. 
These objectives were not able to be determined in isolation from the significant management 
changes that were introduced by the owner in response to both his critical mortality situation and the 
increasingly severe drought throughout much of the study period. However the project did clearly 
demonstrate that a combination of management changes leading to a marked reduction in ‘sheep-
years at risk’ with vaccination was able to markedly reduce mortality rates of all ages of sheep on 
the property and reduce environmental contamination with Mptb.  
(iii) To investigate the relationship between the mortality rate in the flock and the effect of 
vaccination on;  
(a) The seroprevalence of OJD in the flock and in each age group of the flock. 
(b) The proportion of the two-year-old sheep that are excreting Mptb. 
(c) The proportion of the flock having lesions of OJD at slaughter.  
These objectives were met. The seroprevalence of the majority of age groups of control sheep was 
determined over time, suggesting that it remained consistently high in all age groups throughout the 
trial, with the 2.6year old cohort consistently having the highest rate of seroprevalence in all years of 
the study. The excretion rate of 2-year-old sheep over time was determined and a sheep vaccinated 
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at age 3 months in two successive lamb drops and age 8 months, had a much lower prevalence of 
faecal shedders at age 2 years than both non-vaccinated control groups and sheep vaccinated at 2 
years of age. The proportion of a sample of the flock having lesions of OJD at slaughter at the 
abattoir or on-farm was high, being 85.3% with thickening of the bowel suggesting gross lesions of 
OJD, with 79.3% confirmed with histological lesions of OJD. 
The 015 Extension project was developed to estimate the change in pasture contamination by OJD 
from vaccinated adult sheep, by measuring faecal excretion rate of Mptb. from stored faecal 
samples. The additional objectives were: 
(iv)  To determine the Mptb. excretion rates in tagged 1998drop (2-year old) sheep 
collected in 2000, prior to their vaccination in 2000, compared with their excretion rates at ages 3 to 
5, in vaccinated and unvaccinated sheep.  
This objective was met. A much higher rate of excretion Mptb. was found in 1998-drop sheep 
collected in 2000, compared to that in both 2-year-old vaccinated and control sheep when 3, 4 and 5 
years of age. However rather than suggesting the vaccine reduced the prevalence of faecal 
shedders, the results are considered most likely due to the departure due to mortality or culling of 
clinically affected sheep from the flock after 2 year of age, as reflected in the inventory records.  
(v) To determine the Mptb. excretion rates in tagged 1999-drop sheep (3-year old) 
vaccinated (at 8 months of age) and unvaccinated sheep, collected in 2002, and 
compare with the rates in tagged 2000-drop sheep (2-year old) vaccinated (at 3 
months of age) and unvaccinated sheep, collected in 2002. 
This objective was met. Excretion rates of 2-year old sheep vaccinated at age 3 months in two 
successive lamb drops and age 8 months, had a lower prevalence of faecal shedders at age 2 years 
than non-vaccinated control groups, particularly in the ewe flock, where there were no positive 
pooled cultures in vaccinated groups.  
(vi) To examine the relationship between vaccination lesions and presence of OJD 
lesions by histology. 
This objective was met however no evidence of a relationship between vaccination injection lesions 
and presence of OJD lesions was observed.   
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6 Impact on meat and livestock industry 
Prior to the introduction of Gudair™ vaccination, OJD in Australia was widely considered as one of 
the major animal health problems facing the livestock industries. OJD had effectively divided the 
sheep industry, with lobbying for regulation by the OJD-free areas and more intense lobbying for de-
regulation in infected areas by producers financially compromised by trading restrictions. Enormous 
political sensitivity and emotion had been generated in the NSW sheep industry with intense 
criticism of the regulatory authorities and personnel involved in managing the disease.  
 
OJD control by regulation was seen as a punitive strategy compromising the livelihood of affected 
producers and eradication by de-stocking was widely disputed as a viable disease control 
alternative. Many affected producers were promulgating OJD vaccination as their most palatable 
option of OJD control. Whole flock vaccination was considered an option for the most desperate. 
The owners of Merrill were particularly affected by this, having lost their stud business and possibly 
their reputation for quality sheep management. At the time this project was conceived, they 
considered OJD vaccination as their only possible strategy for rescuing their business and whole 
family future from what they perceived was a very dire and seemingly hopeless situation. Although 
other disease control strategies were discussed and doubts cast as to the efficacy of vaccinating 
adults in such a high prevalence environment, the owners of Merrill were desperate to pursue this 
strategy. Arguments were prepared and accepted by the CVO and DCAI to support the strategy 
provided research data could be generated.  
 
As it transpired, institution of vaccination appeared to partially alleviate the enormous stress suffered 
by the owners of Merrill and other disease control strategies could then be instituted. Thus the 
immediate impact on the livestock industry of commencing this trial was the positive influences 
generated by providing a rescue strategy for a property in deep trouble with OJD losses.  
 
The situation at Merrill generated keen interest from local and regional producers and the Merino 
industry in particular. Many of these producers were also suffering economic losses from the 
mortalities, plus the economic and psychological pressure from regulatory controls and the stigma 
attached to a positive diagnosis of OJD. For this reason, ongoing results from the project, which 
were keenly sought by industry and producers throughout the study period, were presented annually 
at conferences and meetings. The positive results of the this project and the related vaccine trial 
project (OJD.009) and the eventual registration of the vaccine in April 2002, generated a palpable 
release of ‘OJD pressure’ in the rural sector. The positive results emerging from both studies 
confirmed that sheep producers now had a tool that would allow OJD to become another disease 
and management issue and the continuous barrage of letters in The Land against the OJD program 
largely faded.  
 
Annual updates of the project have been presented at conferences in Australia between 2001 and 
2005, at the International Sheep Veterinary Congress in Greece in 2005 and at the International 
Colloquia on Paratuberculosis in Spain in 2002 and Denmark in 2005 (Appendix 2). In addition, 
informal advice on progress of the project has been provided on a continuing basis to industry 
personnel including animal health policy makers and at numerous producer meetings in eastern 
Australia. Use of Gudair™ appears already to be a routine practice in many infected flocks and at 
the time of writing over 7million doses had been sold. 
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7 Conclusions 
In a flock with a very high prevalence of mortalities, investigations confirmed that the majority of 
losses were attributable to OJD, supporting a strategy to study whether whole flock vaccination with 
Gudair™ would alleviate the losses. Due to this being a longitudinal field trial on a real world 
property, flock management decisions were made independently of the aims and objectives of the 
trial and we were unable to separate the effect of changing the flock profile from the effects of 
vaccination.  
 
This trial examined sheep in a number of successive generations in only one very high prevalence 
flock. A small but significant number of unvaccinated control sheep were present in all cohorts and 
this was considered necessary to facilitate measurement of the effects of vaccination between 
vaccinates and controls. However the usual practice on most properties is to vaccinate all lambs 
over successive years, so the problem of several hundred unvaccinated sheep being a source of 
potential contamination with Mptb. is ultimately avoided. The trial design was further complicated at 
Merrill by owner management decisions in response to the overwhelming mortality rate and drought, 
leading to extensive culling and replacement of ill and ‘at risk’ sheep. Therefore research to monitor 
the use of vaccination in successive generations where unvaccinated control sheep are not retained 
and ‘at risk’ sheep not readily disposed of, is important to demonstrate what Gudair™ is likely to be 
doing in real world situations, particularly on farms of differing OJD prevalence.  
 
In a sense this project was a “worst-case scenario” from the perspective of OJD, being by far the 
highest level of OJD-attributable mortality recorded during the current epidemic of OJD in Australia. 
As it can be expected that vaccination will be more effective when combined with the type of 
management procedures that occurred at Merrill, then when used alone, the trial has proven to be a 
very valuable demonstration of what can be achieved when extreme management and vaccination 
strategies are applied. The results of other studies and field experience over many years will be 
necessary to gain a clearer picture of what can be achieved by vaccination alone. 
  
High levels of excretion by vaccinates with multibacillary OJD prior to death indicates there is 
considerable risk that some vaccinated sheep could transfer the disease. This has implications for 
translocation of vaccinated sheep to very low prevalence areas, and implies that sustained vaccine 
use will be necessary to avoid recrudescence in heavily infected flocks.  
 
Specific recommendations from this trial are: 
1. Continue on-going research into the efficacy of vaccination over several generations of 
sheep on farms of varying OJD prevalence.  
2. Review the likely effectiveness of on-going research into the efficacy of vaccination and 
duration of immunity in low challenge environments 
3. Consider the value of extension of the limitations of vaccination in control programs for OJD. 
4. Consider the value of extension of the role of flock management in addition to vaccination in 
the control of OJD  
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9 Appendices 
9.1 Appendix 1: OJD histological lesion classification system  
This classification system was modified from Perez et al. 1996. 
 
Type 1 Lesions   
Location  
• only in the lymphoid tissue, never in the intestinal mucosa. 
• PPs: interfollicular spaces, in the basal zone, less often at the apex 
• MLNs: paracortex or interfollicular area, related to subcapsular or peritrabecular sinuses 
(MLN less often affected than PP) 
• Type 
• granulomata formed by macrophage-like cells (nuclei large and clear with obvious 
nucleoli, abundant slightly foamy cytoplasm, lightly stained by H&E and sometimes with clear 
vacuoles) often with small numbers of lymphocytes and cells with elongated nuclei 
• no AFB are seen. 
 
Type 2 Lesions 
• Type 
• granulomata well delineated, round, variable in number, never enough to result in 
diffuse enteritis 
• AFB occasionally seen in granulomata in mucosa, but not in PPs/MLNs. 
• Location 
• PPs: granulomata in a row from the most basal zone of the interfollicular area to the 
apex, penetrating into the lamina propria. Granulomata in the villi are always associated with 
granulomata in an adjacent PP 
• MLNs: similar to Type 1 lesions. Less frequently seen than those in PPs and always 
smaller in size 
 
Type 3 Lesions 
• Granulomatous lesions affect PPs, associated mucosa and mucosa that is not associated with 
lymphoid tissue. There are 3 subtypes: 
 
SubType 3a 
• Type 
• Lesions sporadic, multi-focal 
• AFB are seen in granulomata in the mucosa  
• Location 
• PPs and associated mucosa: 
- lesions are similar to Type 2 
- granulomata in the lamina propria are larger, extend from PPs, involve more villi, cause 
enlargement of villi 
• Areas of mucosa not associated with PP’s: 
- granulomata are small and well delineated in lamina propria of  villi and/or the basal area 
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• Submucosa and serosa: 
- foci of inflammatory cells (mostly lymphocytes and macrophages) are seen around 
lymphatic and blood vessels 
• MLNs: granulomatous lesions  
 
SubType 3b (Multibacillary) 
• Type 
• Diffuse granulomatous enteritis creates a mosaic formed by macrophages, epithelioid 
cells, a few giant cells (2-3 nuclei), small numbers of lymphocytes and other leukocytes 
• AFB in abundance, numbers in mucosa > than in lymphoid tissue. 
• Location 
• PPs: granulomata in the interfollicular areas, follicles and domes, with infiltrates giving a 
mosaic-like appearance, among lymphoid aggregates 
• Mucosa:  
- villi thickened, apices flat and wide, fused, fewer crypts due to infiltration 
- in some sheep the mucosa is less thickened, epithelioid cells are seen in the villi (mostly 
the apex) and diffuse enteritis is due to confluence of numerous small granulomata 
• Submucosa: 
- lymphocyte and plasma cell infiltrates, initially perivascular, but extending to the muscular 
layer, with lymphatics dilated and thrombi composed of macrophages seen within 
• Serosa: 
- Lymph-angitis/angiectasis, perivascular lymphocyte/plasma cell aggregates  
• MLN’s: 
- multi-focal or diffuse granulomatous lymphadenitis 
- subcapsular sinuses usually contain macrophages 
- serosal lesions similar to those in the gut serosa 
 
SubType 3c (Paucibacillary) 
• Type 
• diffuse granulomatous enteritis, but the cell types differ from Type 3b 
• AFB rarely seen, and then only in small numbers. 
• Location 
• PPs: 
- lesions similar to Type 3b, but with pyknotic macrophages and giant cells 
• Mucosa: 
- diffuse granulomatous enteritis, but the predominant cells are lymphocytes in the lamina 
propria of the villi and the basal area; macrophages are seen among the lymphocytes 
either scattered or in small, well defined granulomata of up to 20-25 cells 
• Submucosa: 
- frequently oedema, with variable numbers of lymphocytes and plasma cells 
• Serosa: similar to Type 3b 
• MLNs: 
- multifocal granulomata in the paracortical and interfollicular areas 
- Langhans giant cells (some with >30 nuclei) may be present 
- pyknotic macrophages and perivascular infiltrates are seen in the serosa of the LNs 
 
NSL lesions – No significant lesion 
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9.2 Appendix 2. Publications arising from this project 
 
Throughout this study, the results of the trials have been keenly sought by both producers and 
industry. The project collaborators have regularly attended producer meetings and discussed the 
interim results of the project. Updates of this and related projects have also been presented 
regularly, usually as conference proceedings. Final publication of the results in peer-reviewed 
literature is planned.  
 
Publications arising directly or indirectly from the project are listed in reverse chronological order.  
 
• Windsor PA. (2005) Research into vaccination against OJD in Australia. Keynote address. In: 
Proceedings, 6th International Sheep Veterinary Congress, Crete, June. p. tba 
• McGregor H, Whittington RJ, Windsor PA. (2005) A comparison of the efficacy of Gudair 
vaccine for protection against OJD in sheep aged 3 months and 8 months at vaccination. In: 
Proceedings, 6th International Sheep Veterinary Congress, Crete, June. p. tba 
• Windsor PA (2005) Control of OJD by vaccination. In: Proceedings of the Australian Sheep 
Veterinary Society Annual Meeting – Gold Coast Conference, May, Volume 15: 129-133 
• Eppleston J, Reddacliff L, Windsor P, Whittington R, Jones S. Field studies on vaccination for 
the control of OJD in Australia: an overview. In: Proceedings of the Australian Sheep 
Veterinary Society 2004 – Canberra Conference, May, Volume 14, 56-59. 
• Windsor PA (2004) Syndromes of wasting & alimentary tract disease. In: Proceedings 355 
Postgraduate Refresher Course for Veterinarians in Sheep Medicine. Pub. by Postgraduate 
Foundation in Veterinary Science, University of Sydney. EMAI, May 2004, p 16-28. 
• Eppleston J, Reddacliff L, Windsor P, Whittington R and Jones S. (2003) An update on the 
efficacy of GudairTM OJD Vaccine in Australia. In: Proceedings of the Australian Sheep 
Veterinary Society 2003 – Cairns Conference, Volume 13, 107-113 
• Windsor P, Eppleston J, Sergeant E, Reddacliff L, McGregor H, Bush R, Toribio J and 
Whittington R. (2003) Monitoring the efficacy of GudairTM OJD vaccine in Australia. 
Proceedings of the Australian Sheep Veterinary Society 2003 – Cairns Conference, May, 
Volume 13, 114-120 
• McGregor H, Windsor PA, Abbott KA..(2003) A longitudinal study of ovine Johne’s disease: 
estimation of the mortality rate two years after whole-flock vaccination. In: Proceedings of the 
Australian Sheep Veterinary Society 2003 – Cairns Conference, May, Volume 13, 102-106.  
• Abbott KA, McGregor H, Windsor PA, Britton A.. (2002) The paratuberculosis attributable 
mortality rate in a flock of sheep of Merino sheep in Australia. In: Proceedings of the Seventh 
International Colloquium on Paratuberculosis, June 2002, Bilbao, Spain, 345-350 
• McGregor H, Windsor PA, Abbott KA.. (2002) A longitudinal study of OJD and the effects of 
whole flock vaccination with Gudair. In: Proceedings of the Australian Sheep Veterinary 
Society 2002 – Adelaide Conference, May, Volume 12, 17-21. 
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Australian Sheep Veterinary Society 2001 – Melbourne Conference, May, Volume 11, 68-74. 
